Tirzepatide

TIRZEPATIDE BY DRAGON PHARMA

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
 - active substance: tirzepatide 5 mg;
 - auxiliary substances:

LABORATORY TEST REPORT

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Human Peptide Hormone.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: N/A
Routes of administration: subcutaneous injection
Dosage forms: (Men): N/A; (Women): -
Acne: n/a
Water retention: n/a
High blood pressure: n/a
Hepatotoxicity: n/a
Aromatase: n/a
Decreased HPTA function (own testosterone production): n/a
Anabolic activity: N/A
Androgenic activity: N/A
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 5 mg / 2 mL in 2 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe